Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H18F3NO.ClH |
Molecular Weight | 321.766 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C[C@H](CN1CCCC1)C(=O)C2=CC=C(C=C2)C(F)(F)F
InChI
InChIKey=PHBZFPOOJUGYCR-RFVHGSKJSA-N
InChI=1S/C15H18F3NO.ClH/c1-11(10-19-8-2-3-9-19)14(20)12-4-6-13(7-5-12)15(16,17)18;/h4-7,11H,2-3,8-10H2,1H3;1H/t11-;/m1./s1
Molecular Formula | C15H18F3NO |
Molecular Weight | 285.3047 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16126840
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16126840
Lanperisone (NK433) is muscle relaxant. It acts by blocking voltage-gated sodium channels.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2331043 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16126840 |
13.7 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9430412
In studies of muscle relaxation effect on rats and cats, NK433 was administered either parenterally via a cannula previously inserted into the jugular, cephalic or femoral vein. In oral administration study, NK433 was dissolved in distilled water and was administered via a cannula previously inserted into the stomach. NK433 reduced the mono- and polysynaptic reflex potential at doses of 5 and 10 mg/kg, i.v.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16126840
Binding to Voltage-gated sodium channels was studied using [3H]batrachotoxinin A 20-alpha-benzoate ([3H]-BTX) assay with rat cerebrocortical synaptosomes. Aliquots (100 μL) equal to approximately 6 to 8 mg/ml protein were used in [3H]BTX binding experiments. Binding assays were performed in the presence of 5.0 nM [3H]BTX, 1 μΜ tetrodotoxin, 4.0 μg of scorpion toxin, and various concentrations of the added drugs at 37°C for 60-min incubation time. Nonspecific binding was determined in the presence of 300 μΜ aconitine. The reaction was terminated by rapid filtration using a UniFilter-96 GF/B (PerkinElmer Life and Analytical Sciences). The filtration plates were washed five times with ice-cold wash buffer. Radioactivity trapped on a 96-well filtration plate was measured by liquid scintillation spectrometry in 40 μL of Mi-croscint 20 scintillation cocktail. Binding affinity of lanperisone was determined to be 13.7 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:12:37 GMT 2023
by
admin
on
Sat Dec 16 05:12:37 GMT 2023
|
Record UNII |
JRF22NV56M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
116287-13-9
Created by
admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
|
PRIMARY | |||
|
JRF22NV56M
Created by
admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
|
PRIMARY | |||
|
31762
Created by
admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
|
PRIMARY | |||
|
198706
Created by
admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
|
PRIMARY | |||
|
DTXSID4048856
Created by
admin on Sat Dec 16 05:12:37 GMT 2023 , Edited by admin on Sat Dec 16 05:12:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|